IFNB1 and myeloid sarcoma: This is in agreement with our previous studies in which IFN-β expression was enhanced following DNA vaccination [7] as well as a study in IFN-β-treated MS patients using microarrays that revealed upregulation of genes with IFN-responsive promoter elements but no alterations in Th1- or Th2-associated genes [31].